| Application no. and date | 01995705.9 (espacenet) (Federated) (European Patent Register), 20011220 | | Patent/reg. no. and date | DK/EP 1343523, 20070214 | | Publication date | 20030917 | | Priority no. and date | EP 00128252, 20001221 | | EP pub. no. and date |
EP 1343523 20030917 | | Effective date | | | Applicant/owner | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG,
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 128207 | | Inventor | WIENEN, Wolfgang, Kirschenweg 27
88400 Biberach, DE,
SKAMIRA, Cord, Zur Mühle 16
88444 Ummendorf, DE,
STASSEN, Jean, Marie, Joseph Ravoetstrasse 5
B-3012 Leuven, BE,
HEUSEL, Gerhard, Buchenweg 6
88444 Ummendorf, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61P 7/04 (2006.01) | | Title | Anvendelse af aktiveret faktor VII til behandling af thrombolytisk terapi-inducerede alvorlige blødninger | | Int. application no. | EP2001015132 | | Int. publication no. | WO2002049665 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
